x

Evoke Pharma Inc (Nasdaq:EVOK)

Health Care/Life Sciences • Pharmaceuticals
CIK 1403708
Company

Evoke Pharma, Inc. is a pharmaceutical company, which engages in the development of drugs for the treatment of gastrointestinal disorders and diseases. It also develops Gimoti, with promotility and anti-emetic effects, for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women with diabetes mellitus. The company was founded by Matthew J. D'Onofrio, Cam L. Garner, Scott L. Glenn, and David A. Gonyer in January 2007 and is headquartered in Solana Beach, CA.

Address
420 Stevens Avenue
Suite 370
Solana Beach, California 92075-2074
Employees
4
Stock Info
Close
$0.6790
Day Range
0.6072 - 0.6800
52 Week Range
0.5577 - 3.7000
Average volume
51.05K
Short Interest
219.82K (02/15/24)
% of Float Shorted
2.65%
Market Cap
$5.64M
Revenue
$2.51M
Net Income
-$8.22M
2020 Sales Growth
N/A
Rev. per Employee
$1.075M
P/E Ratio
N/A
EPS
-$2.2758
Yield
N/A
Dividend
N/A
Ex-Dividend Date
N/A
Key Executives
Board Of Directors
Chief Executive Officer & Director
David A Gonyer
Chairman
Cam L Garner MBA
Independent Director
Todd C Brady MD, PhD
Independent Director
Malcolm R Hill PharmD
Independent Director
Kenneth J Widder MD
Independent Director
Vickie W Reed CPA
SEC filings
DateFormEvent
1 Oct, 2024 SC 13D/A
27 Sep, 2024 424B3
27 Sep, 2024 8-K
20 Sep, 2024 SC 13D
6 Sep, 2024 EFFECT
4 Sep, 2024 CORRESP
3 Sep, 2024 UPLOAD
29 Aug, 2024 S-3
21 Aug, 2024 EFFECT
19 Aug, 2024 CORRESP
16 Aug, 2024 8-K
16 Aug, 2024 UPLOAD
13 Aug, 2024 8-K
13 Aug, 2024 S-3
13 Aug, 2024 10-Q
8 Aug, 2024 4
8 Aug, 2024 4
8 Aug, 2024 4
1 Aug, 2024 8-K
20 Jun, 2024 8-K
7 Jun, 2024 8-K
30 May, 2024 3
28 May, 2024 8-K
24 May, 2024 4
24 May, 2024 4
24 May, 2024 4
24 May, 2024 4
24 May, 2024 4
15 May, 2024 DEFA14A
14 May, 2024 10-K/A
14 May, 2024 10-Q
14 May, 2024 ARS/A
14 May, 2024 8-K
14 May, 2024 8-K
10 Apr, 2024 DEF 14A
10 Apr, 2024 ARS
10 Apr, 2024 DEFA14A
29 Mar, 2024 PRE 14A
25 Mar, 2024 8-K
25 Mar, 2024 424B3
21 Mar, 2024 8-K CEO Change
18 Mar, 2024 8-K
15 Mar, 2024 POS EX
15 Mar, 2024 424B3
14 Mar, 2024 10-K
14 Mar, 2024 8-K
13 Mar, 2024 SC 13G
11 Mar, 2024 SC 13G
23 Feb, 2024 8-K
20 Feb, 2024 SC 13G
14 Feb, 2024 8-K
13 Feb, 2024 SC 13G
9 Feb, 2024 424B4
9 Feb, 2024 8-K
8 Feb, 2024 S-1/A
8 Feb, 2024 EFFECT
7 Feb, 2024 CORRESP
7 Feb, 2024 CORRESP
17 Jan, 2024 CORRESP
17 Jan, 2024 CORRESP
16 Jan, 2024 CORRESP
16 Jan, 2024 CORRESP
11 Jan, 2024 CORRESP
11 Jan, 2024 S-1/A
11 Jan, 2024 CORRESP
5 Jan, 2024 CORRESP
5 Jan, 2024 CORRESP
4 Jan, 2024 S-1/A
19 Dec, 2023 S-1/A
15 Dec, 2023 S-1/A
29 Nov, 2023 8-K
27 Nov, 2023 8-K
22 Nov, 2023 8-K
15 Nov, 2023 UPLOAD
9 Nov, 2023 S-1
9 Nov, 2023 8-K
9 Nov, 2023 10-Q
1 Nov, 2023 8-K
12 Oct, 2023 8-K
11 Aug, 2023 S-8
10 Aug, 2023 10-Q
10 Aug, 2023 8-K
21 Jul, 2023 8-K
26 May, 2023 8-K
18 May, 2023 CT ORDER
15 May, 2023 10-Q
15 May, 2023 8-K
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 4
11 May, 2023 8-K
9 May, 2023 8-K
1 May, 2023 8-K
20 Apr, 2023 8-K
6 Apr, 2023 8-K
29 Mar, 2023 ARS
29 Mar, 2023 DEF 14A
29 Mar, 2023 DEFA14A
23 Mar, 2023 8-K
21 Mar, 2023 10-K
21 Mar, 2023 8-K
17 Mar, 2023 PRE 14A
21 Feb, 2023 8-K
13 Feb, 2023 8-K CEO Change
10 Feb, 2023 4
10 Feb, 2023 4
10 Feb, 2023 4
30 Jan, 2023 8-K
30 Nov, 2022 8-K
9 Nov, 2022 10-Q
9 Nov, 2022 8-K
20 Sep, 2022 8-K
26 Aug, 2022 8-K
10 Aug, 2022 10-Q
10 Aug, 2022 8-K
8 Jun, 2022 8-K
23 May, 2022 8-K
20 May, 2022 8-K
10 May, 2022 10-Q
10 May, 2022 8-K
28 Apr, 2022 4
28 Apr, 2022 8-K
28 Apr, 2022 4
28 Apr, 2022 4
28 Apr, 2022 4
28 Apr, 2022 4
26 Apr, 2022 8-K
26 Apr, 2022 424B5
15 Mar, 2022 DEFA14A
15 Mar, 2022 DEF 14A
15 Mar, 2022 DEFA14A
8 Mar, 2022 10-K
8 Mar, 2022 8-K
4 Mar, 2022 PRE 14A
24 Feb, 2022 8-K
17 Feb, 2022 8-K
4 Feb, 2022 4
4 Feb, 2022 4
4 Feb, 2022 4
2 Feb, 2022 8-K
4 Jan, 2022 8-K
30 Dec, 2021 8-K
10 Nov, 2021 8-K
10 Nov, 2021 10-Q
20 Oct, 2021 8-K
29 Sep, 2021 8-K
12 Aug, 2021 10-Q
12 Aug, 2021 8-K
2 Aug, 2021 8-K
23 Jul, 2021 4
23 Jul, 2021 4
23 Jul, 2021 4
23 Jul, 2021 4
23 Jul, 2021 4
14 Jul, 2021 8-K
29 Jun, 2021 8-K
15 Jun, 2021 8-K
8 Jun, 2021 8-K
2 Jun, 2021 8-K
17 May, 2021 3
17 May, 2021 4
14 May, 2021 8-K
12 May, 2021 8-K
12 May, 2021 10-Q
6 May, 2021 SC 13G
6 May, 2021 8-K
6 Apr, 2021 8-K
26 Mar, 2021 DEF 14A
26 Mar, 2021 SC 13G/A
26 Mar, 2021 DEFA14A
23 Mar, 2021 SEC STAFF
12 Mar, 2021 PRE 14A
11 Mar, 2021 8-K
11 Mar, 2021 10-K
23 Feb, 2021 SEC STAFF
29 Jan, 2021 4
29 Jan, 2021 4
29 Jan, 2021 4
20 Jan, 2021 SC 13G
14 Jan, 2021 424B5
14 Jan, 2021 8-K
13 Jan, 2021 8-K
13 Jan, 2021 424B5
6 Jan, 2021 EFFECT
4 Jan, 2021 CORRESP
28 Dec, 2020 UPLOAD
Last update:2024-03-06 12:37:18.667272
Evoke Pharma Inc by TradingView

Sign Up to Subscribe